Detailed information for compound 1309948

Basic information

Technical information
  • TDR Targets ID: 1309948
  • Name: 4-[2-[2-(3-methoxypropylamino)-2-oxoethyl]sul fanyl-4-oxoquinazolin-3-yl]-N-(oxolan-2-ylmet hyl)butanamide
  • MW: 476.589 | Formula: C23H32N4O5S
  • H donors: 2 H acceptors: 3 LogP: 1.39 Rotable bonds: 15
    Rule of 5 violations (Lipinski): 1
  • SMILES: COCCCNC(=O)CSc1nc2ccccc2c(=O)n1CCCC(=O)NCC1CCCO1
  • InChi: 1S/C23H32N4O5S/c1-31-13-6-11-24-21(29)16-33-23-26-19-9-3-2-8-18(19)22(30)27(23)12-4-10-20(28)25-15-17-7-5-14-32-17/h2-3,8-9,17H,4-7,10-16H2,1H3,(H,24,29)(H,25,28)
  • InChiKey: ALSKVQWMEMPELH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-[2-[2-(3-methoxypropylamino)-2-oxo-ethyl]sulfanyl-4-oxo-quinazolin-3-yl]-N-(tetrahydrofuran-2-ylmethyl)butanamide
  • 4-[2-[[2-(3-methoxypropylamino)-2-oxoethyl]thio]-4-oxo-3-quinazolinyl]-N-(2-tetrahydrofuranylmethyl)butanamide
  • 4-[4-keto-2-[[2-keto-2-(3-methoxypropylamino)ethyl]thio]quinazolin-3-yl]-N-(tetrahydrofurfuryl)butyramide
  • 4-[2-[2-(3-methoxypropylamino)-2-oxo-ethyl]sulfanyl-4-oxo-quinazolin-3-yl]-N-(oxolan-2-ylmethyl)butanamide
  • MLS000095324
  • MLS000863713
  • SMR000030878
  • 4-[2-({2-[(3-methoxypropyl)amino]-2-oxoethyl}thio)-4-oxoquinazolin-3(4H)-yl]-N-(tetrahydrofuran-2-ylmethyl)butanamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens GNAS complex locus Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K04632 guanine nucleotide binding protein (G protein), alpha stimulating, putative Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain Get druggable targets OG5_131088 All targets in OG5_131088
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative Get druggable targets OG5_131088 All targets in OG5_131088

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni GTP-binding protein alpha subunit gna GNAS complex locus 394 aa 450 aa 28.7 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus jun protein 0.0099 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0898 0.0674
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0898 1
Brugia malayi hypothetical protein 0.003 0.0898 0.0514
Brugia malayi hypothetical protein 0.0039 0.2049 0.1713
Trypanosoma brucei unspecified product 0.0075 0.6819 0.877
Leishmania major DNA polymerase eta, putative 0.0081 0.7567 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0044 0.2745 0.3199
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Giardia lamblia DINP protein human, muc B family 0.0061 0.4992 1
Mycobacterium ulcerans DNA polymerase IV 0.0082 0.7719 0.5
Loa Loa (eye worm) hypothetical protein 0.0096 0.964 1
Leishmania major DNA polymerase eta, putative 0.0043 0.2575 0.3029
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Loa Loa (eye worm) hypothetical protein 0.003 0.0898 0.0534
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0054 0.4092 0.3992
Trypanosoma cruzi DNA polymerase kappa, putative 0.0082 0.7719 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0061 0.4992 1
Schistosoma mansoni hypothetical protein 0.008 0.7537 0.9961
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.4193 0.5504
Leishmania major hypothetical protein, conserved 0.003 0.0898 0.0688
Schistosoma mansoni DNA polymerase eta 0.0081 0.7567 1
Schistosoma mansoni hypothetical protein 0.0039 0.2049 0.2646
Schistosoma mansoni jun-related protein 0.008 0.7537 0.9961
Leishmania major DNA polymerase kappa, putative 0.0061 0.4992 0.6405
Trypanosoma cruzi DNA polymerase eta, putative 0.0043 0.2575 0.2966
Loa Loa (eye worm) hypothetical protein 0.0081 0.7567 0.7755
Trypanosoma brucei DNA polymerase eta, putative 0.0081 0.7567 0.9792
Trichomonas vaginalis DNA polymerase eta, putative 0.0082 0.7719 1
Trypanosoma brucei unspecified product 0.0038 0.1846 0.1969
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0898 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.4193 0.3948
Schistosoma mansoni transcription factor LCR-F1 0.0039 0.2049 0.2646
Trypanosoma brucei DNA polymerase kappa, putative 0.0044 0.2745 0.3199
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.4193 0.3948
Echinococcus granulosus dna polymerase eta 0.0081 0.7567 0.7464
Brugia malayi hypothetical protein 0.0078 0.7177 0.7058
Trypanosoma brucei unspecified product 0.0038 0.1846 0.1969
Brugia malayi polk-prov protein 0.0044 0.2727 0.242
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.4193 0.3948
Trypanosoma brucei DNA polymerase kappa, putative 0.0044 0.2727 0.3174
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.0898 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.0898 0.0674
Trypanosoma cruzi DNA polymerase kappa, putative 0.0082 0.7719 1
Echinococcus multilocularis jun protein 0.0099 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0082 0.7719 1
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0054 0.4092 0.5369
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0898 0.0674
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.0099 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.4193 0.5504
Brugia malayi ImpB/MucB/SamB family protein 0.0054 0.4092 0.3842
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0054 0.4092 0.3842
Entamoeba histolytica hypothetical protein 0.0039 0.2049 0.4459
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0039 0.2049 0.1713
Trypanosoma cruzi DNA polymerase kappa, putative 0.0082 0.7719 1
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0061 0.4992 0.6405
Trypanosoma cruzi DNA polymerase eta, putative 0.0081 0.7567 0.9792
Mycobacterium ulcerans DNA polymerase IV 0.0082 0.7719 0.5
Toxoplasma gondii flap structure-specific endonuclease 1, putative 0.0027 0.0405 0.1575
Entamoeba histolytica deoxycytidyl transferase, putative 0.0054 0.4092 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0055 0.4193 0.4102
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Toxoplasma gondii LsmAD domain-containing protein 0.003 0.0898 0.3489
Onchocerca volvulus 0.0078 0.7177 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0075 0.6819 0.877
Trypanosoma brucei DNA polymerase kappa, putative 0.0044 0.2745 0.3199
Entamoeba histolytica hypothetical protein 0.0039 0.2049 0.4459
Schistosoma mansoni terminal deoxycytidyl transferase 0.0054 0.4092 0.5369
Trypanosoma cruzi DNA polymerase kappa, putative 0.0082 0.7719 1
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.0099 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0082 0.7719 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0055 0.4193 0.3948
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0039 0.2049 0.1713
Loa Loa (eye worm) hypothetical protein 0.0044 0.2727 0.2514
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.4193 0.5504
Echinococcus multilocularis dna polymerase eta 0.0081 0.7567 0.7464
Entamoeba histolytica hypothetical protein 0.0039 0.2049 0.4459
Entamoeba histolytica hypothetical protein 0.0039 0.2049 0.4459
Trypanosoma brucei DNA polymerase kappa, putative 0.0044 0.2727 0.3174
Trypanosoma brucei DNA polymerase kappa, putative 0.0082 0.7719 1
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0082 0.7719 1
Echinococcus granulosus dna polymerase kappa 0.0082 0.7719 0.7623
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.4193 0.3948
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0054 0.4092 0.3842
Toxoplasma gondii ImpB/MucB/SamB family protein 0.0043 0.2575 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0061 0.4992 0.6271
Brugia malayi ImpB/MucB/SamB family protein 0.0081 0.7567 0.7464
Echinococcus multilocularis dna polymerase kappa 0.0082 0.7719 0.7623

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.0029 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 3.1623 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 3.5481 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 25.1189 um PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.